Scientists have developed a proof-of-concept vaccine that could offer broad protection against all known and emerging variants of highly pathogenic avian influenza (A5) viruses, including those that have yet to evolve.
The one-shot vaccine, described in the journal Nature, could significantly strengthen defences against the threat of a future pandemic.
Mathilde Rochard of Erasmus University Medical Centre in the Netherlands and her team created a high-resolution 3D map showing how the H5 haemagglutinin (HA) protein has changed over decades. The map revealed the full evolutionary history and diversity of H5 strains.
Using this map, the researchers designed a synthetic HA protein that sits at the antigenic centre of all known H5 variants. Although not an exact match for every strain, it is the closest to all existing and potential future viruses. By exposing the immune system to this central antigen, the vaccine aims to trigger a broad antibody response capable of fighting a wide range of H5 infections.
Tests in ferrets, a common model for influenza studies, showed that the vaccine provided strong protection against multiple, distinct H5 strains, comparable to strain-specific vaccines, and even against two viruses not included in the formulation.
While the findings are promising, the researchers cautioned that human trials are still needed to confirm the vaccine’s safety and effectiveness.
From Emirates 24/7
Agreement reflects the UAE’s commitment to supporting sport and advancing cycling development Dubai, 1 September…
From AI agents and smart manufacturing to investment opportunities in Syria and partnerships with Chinese…
Dubai, UAE – A multidisciplinary medical team at NMC Specialty Hospital, Al Nahda has successfully…
WORLD BREASTFEEDING WEEK (1st–7th August) Breastfeeding: The First Gift That Lasts a Lifetime By Dr.…
Abu Dhabi, United Arab Emirates Artificial intelligence is entering a defining new era. Across the…
The King Fahad National Library in the Kingdom of Saudi Arabia has selected Face to…